Replimune (REPL) Non Operating Interest Expenses (2019 - 2026)
Replimune's Non Operating Interest Expenses was $2.58 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 75.0% from $1.48 million a year earlier and up 9.0% from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Non Operating Interest Expenses (2019 - 2026) Analysis & Trends
On a trailing twelve-month basis, Replimune's Non Operating Interest Expenses was $7.9 million through Jun 30, 2026, up 35.7% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $6.8 million, up 17.7% from FY2025.
- Non Operating Interest Expenses has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 52.7% (FY2021 to FY2026).
- In earlier fiscal years, Non Operating Interest Expenses was $5.78 million in FY2025 (+28.4%), $4.5 million in FY2024 (+129.1%) and $1.96 million in FY2023.
- The fiscal Q1 2027 figure marks the highest quarterly Non Operating Interest Expenses in data going back to fiscal Q2 2020.
- Compared with a year earlier, Non Operating Interest Expenses has increased for 11 straight quarters, with growth averaging 30.3% over the last eight quarters.
- The year-over-year growth in Non Operating Interest Expenses has ranged between 1.1% (fiscal Q3 2026) and 75.0% (fiscal Q1 2027) over the last five years.
- Per Business Quant data, REPL's Non Operating Interest Expenses in the three fiscal quarters before Q1 2027 was $2.37 million (Q4 2026), $1.47 million (Q3 2026) and $1.49 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Replimune | 1.11 Bn | 1.11 Bn | - | 2.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.58 Mn |
| Mar 31, 2026 | 2.37 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 955,000.00 |
| Jun 30, 2023 | 1.12 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 941,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 247,000.00 |
| Sep 30, 2020 | 286,000.00 |
| Jun 30, 2020 | 284,000.00 |
| Mar 31, 2020 | -295,000.00 |
API Access
Replimune Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();